Universidad de Navarra

Futó vizsgálatok

• Toboroz

  Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

  NCT07415720· Clinica Universidad de Navarra, Universidad de Navarra· Forrás

• Toboroz

  Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

  2022-502352-31-00· 3. fázis· Amgen Inc.· Forrás

• Még nem toboroz

  SHARE Study: Social Chronic Heart Failure Person-centred cARE Intervention

  NCT06701916· Clinica Universidad de Navarra, Universidad de Navarra· Forrás

• Fut, nem toboroz

  Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

  NCT06149650· Cardiovascular and Interventional Radiological Society of Europe· Forrás

• Toboroz

  Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality

  NCT06338215· Clinica Universidad de Navarra, Universidad de Navarra· Forrás

• Toboroz

  Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

  NCT04068597· 1/2. fázis· CellCentric Ltd.· Forrás

• Fut, nem toboroz

  A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

  NCT03873402· 3. fázis· Bristol-Myers Squibb· Forrás

• Fut, nem toboroz

  Childhood Obesity Risk Assessment Longitudinal Study

  NCT06317883· Consorcio Centro de Investigación Biomédica en Red (CIBER)· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• 2-es típusú cukorbetegség2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Elhízás1 toboroz
• Liver cirrhosis1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Mielóma multiplex1 toboroz
• Szívelégtelenség1 toboroz
• Tuberkulózis1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  TACTIVE-U: An Umbrella Study to Investigate the Safety and Antitumor Activity of vepdegestrant (ARV-471) in Combination With Other Medicines in Adults With ER+ Advanced or Metastatic Breast Cancer, Sub-study C (ARV-471 and Samuraciclib)

  NCT06125522· 1/2. fázis· Pfizer Inc.· Forrás

• Lezárult

  Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

  NCT06576232· Median Technologies· Forrás

• Lezárult

  Retrospective Clinical Trial Comparing Radiologists' Diagnosis Accuracy in Lung Cancer Screening Population With and Without the Help of an AI/ML Tech-based SaMD

  NCT06751576· Median Technologies· Forrás

• Lezárult

  Bemarituzumab plus Chemotherapy and Nivolumab versus Chemotherapy and Nivolumab Alone (FORTITUDE-102)

  NCT05111626· 3. fázis· Amgen Inc.· Forrás

• Leállították

  A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

  NCT04244656· 1. fázis· CRISPR Therapeutics AG· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás